Recombinant IL21 (Avizakimab Biosimilar) antibody

Catalog No. ABIN7597528

The Humanized Chimeric anti-IL21 (Avizakimab Biosimilar) antibody has been validated for . It is suitable to detect IL21 (Avizakimab Biosimilar) in samples from Human.

Quick Overview for Recombinant IL21 (Avizakimab Biosimilar) antibody (ABIN7597528)

Target: IL21 (Avizakimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This IL21 (Avizakimab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-IL21 (Avizakimab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Avizakimab Biosimilar Antibody

Specificity: IL-21, Interleukin-21, IL21, Za11

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 4.2 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for IL21 (Avizakimab Biosimilar)

Target: IL21 (Avizakimab Biosimilar)

Alternative Name: Avizakimab Biosimilar

Target Type: Biosimilar

Background: IL-21, Interleukin-21, IL21, Za11

UniProt: Q9HBE4

CAS-No: 2229685-51-0